ReviewJournal of clinical medicine2022

Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy?

Katarzyna Wołos-Kłosowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.